Dr Brendan Shaw is the principal of Shawview Consulting, the former CEO of Medicines Australia and assistant director-general of the International Federation of Pharmaceutical Manufacturers and Associations. In a special comment, Dr Shaw discusses the recent focus on domestic manufacturing capability. …
New industrial policy for biopharmaceutical and devices industry needs careful thought
April 17, 2020 Latest NewsNews of the Day
Latest Video
Georgia Forrest
New Stories
-
Another potential turning point for immunotherapy access in Australia
February 1, 2026 - - Latest News -
Better Access Australia’s plan to make care fair, affordable and accountable
February 1, 2026 - - Latest News -
Pfizer calls for Budget shift, citing missed medicines and the impact of lost productivity
February 1, 2026 - - Latest News -
Vertex announces PBS listing of new once-daily treatment for cystic fibrosis
February 1, 2026 - - Latest News -
The 'Dispatched' Podcast - Episode 2, Series 5
January 30, 2026 - - Podcast -
New long-term data suggest sustained benefit of Eisai therapy in early Alzheimer’s Disease
January 30, 2026 - - Latest News -
Amgen announces leadership transition for Australia and New Zealand
January 30, 2026 - - Latest News